A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma
Titel:
A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma
Auteur:
Richardson, PG Lonial, S Jakubowiak, A Jagannath, S Raje, N Avigan, D Ghobrial, IM Schlossman, R Mazumder, A Munshi, NC Vesole, D Joyce, R Doss, D Warren, D Lunde, L Lukas, R Kaster, S Shea, K Delaney, C Lauria, M Mitsiades, C Hideshima, T Knight, R Esseltine, DL Anderson, KC